1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Glucose Sensors, the Next Generation : Devices, Technologies, Players and Prospects

The convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Noninvasive glucose monitors that can measure glucose levels accurately and reliably have the capability to improve glycemic control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, noninvasive monitors are creating new options for caregivers and their diabetes patients. Signal processing improvements - include improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of noninvasive monitors.

Highlights

- Analyzes and evaluates emerging glucose sensing technologies and development-stage products and assesses market potential and commercialization risks and opportunities
- Examines glucose sensor design issues and evolving market factors
- Provides detailed status of glucose sensors currently in development
- Forecasts the impact of glucose sensing technology and devices on diabetes management markets and projects probable fu
- Profiles market participants, their technology, product development activity, and business strategies

The study is designed to provide healthcare company decision makers, diabetes management device developers, product marketers, and supply chain participants with a detailed understanding of the technologies, participants and commercial opportunities within the glucose sensing segment of the diabetes management sector. Provider
organization business managers, healthcare administrators and investors will also benefit from this study.

Table Of Contents

Glucose Sensors, the Next Generation : Devices, Technologies, Players and Prospects
Executive Summary

Glucose Sensing Market Overview

Monitoring Glucose Levels
The Addressable Market
Market Drivers
Industry Alignment and Competitive Landscape

New Generation Monitor Design Factors

Measuring Glucose in Interstitial Fluid
Patient/User Interface
Calibration Frequency
Accuracy and Precision
Sensitivity
Sensor Technology and Signal Processing Advances

Next Generation Glucose Sensors - Product Analysis

Optical Sensing
Photoacoustic Spectroscopy
Ocular Imaging
Occlusion Spectroscopy
Wearable Sensors
Minimally Invasive Sensors
Microprobe Arrays
Micropores/Microneedles
Implantable Sensors
Noninvasive Sensors
Biomarker Detection Sensors
Glycosylated End Products
Other Glucose Metabolites

Market Factors

Regulations
FDA
EMEA
Asia
Clinical Trials
Patient/Consumer Sentiment
Diabetes Demographics

Company Profiles

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.